[1]National Cancer Institute.Lung Cancer，2009.

[2]高玉堂.上海市区恶性肿瘤发病率、死亡率和生存率（1973-2000）.上海：第二军医大学出版社，2007：337-338.

[3]Wicha MS，Liu S，Dontu G.Cancer stem cells：An old idea—A paradigm shift.Cancer Res，2006，66：1883-1890.

[4]Stingl J，Eirew P，Ricketson I，et al.Purification and unique properties ofmammary epithelial stem cells. Nature，2006，23；439（7079）：993-997.

[5]Dick JE.Breast cancer stem cells revealed.Proc Natl Acad Sci USA，2003，100（7）：3547-3549.

[6]Weissman IL，Anderson DJ，Gage F.Stem and progenitor cells：Origins，phenotypes，lineage commitments，and trans differentiations.Annu Rev Cell Dev Biol，2001，17：387-403.

[7]Oakley EJ，Van ZantG.Unraveling the complex regulation ofstem cells：implications foragingand cancer. Leukem ia，2007，21：612-621.

[8]Glinsky GV，Beregovska O，Glinskh AB.Microarry analysis identifies a death-from-cancer signature proceeding therapy failure in patients with multiple types of cancer.JClin Invest，2005，115：1503-1521.

[9]AJ-Hajj M，Wicha MS，Benito-Hemandez A，et al.Prospective identification of tumorigenic breast cancer cells.Proc Natl Acad Sci，2003，63：5821-5828.

[10]Singh SK，Hawkins C，Clarke ID，et al.Identification of human brain tumour initiating cells.Nature，2004，432（7015）：396.

[11]Yuan X，Curtin J，Xiong Y，etal.Isolation of cancer stem cells from adultglioblastomamultiforme.Oncogene，2004，23（58）：9392-9400.

[12]Maitland SJ，Coline A.A tumor stem cells hypothesis for the origins of prostate cancer.B JR Int，2005，96（10）：1219-1223.

[13]Tokar EJ，Ancrile BB，Cunha GR，et al.Stem/progenitor and intermediate cell type and the origin of human prostate cancer.Differentiation，2005，73（9-10）：463-473.

[14]Lam JS，Reiter RE.Stem cells in prostate cancer development.UrolOncol，2006，24：（2）：131-140.

[15]Tang DG，Patrawala L，Calhoun T，et al.Prostate cancer stem/progenitor cells：Identification，characterization，and implication.MolCarcinog，2007，46（1）：1-14.

[16]Suratt BT，Cool CD，Serls AE，et al.Human pulmonary chimerism after hematopoietic stem cell transplantation.Am JRespir Crit Care Med，2003，168（3）：267-268.

[17]Loi R，Beckett T，Goncz KK，et al.Limited restoration of cystic fibrosis lung epithelium in vivo with adult bonemarrow-derived cells.Am J Respir Crit Care Med，2006，173（2）：171-179.

[18]Peacock CD，Watkins DN.Cancer Stem Cells and the Ontogeny of Lung Cancer.JClin Oncol，2008，26：2883-2889.

[19]Kim CF，Jackson EL，Woolfenden AE，et al.Identification of bronchioalveolar stem cells in normal and lung cancer.Cell，2005，121（6）：823-835.

[20]Hilbe W，dirnhofer S，Oberwasserlechner F，et al.CD133 Positive endothelial progenitor cells contribute to the tumour vasculature in non-small-cell lung cancer.JClinPathol，2004，57（9）：965-969.

[21]Dome B，Timar J，Dobos J，et al.Identification of bronchioalveolar stem cells in normal lung and lung cancer.Cell，2005，121（6）：823-835.

[22]Haura EB.Is repetitive wounding and bone marrow-derived stem cell mediated-repair an etiology of lung cancer development and dissemination？Med Hypotheses，2006，67（4）：951-956.

[23]Fukazawa T，Maeda Y，Durbin ML，etal.Pulmonary adenocarcinoma-targeted gene therapy by a cancerand tissue-specific promoter system.Mol Cancer Ther，2007，6（1）：244-252.

[24]Giangreco A，Groot KR，Janes SM.Lung Cancer and Lung Stem Cells：Strange Bedfellows？Am JRespir Crit Care Med，2007，175：547-553.

[25]Summer R，Kotton DN，Sun X，et al.Side population cells and Bcrp1 expression in lung.Am JPhysiol Lung Cell MolPhysiol，2003，285：L97-L104.

[26]Giangreco A，Shen H，Reynolds SD，et al.Molecular phenotype of airway side population cells.Am J Physiol Lung Cell MolPhysiol，2004，286：L624-L630.

[27]Kim CB.Advancing the field of lung stem cell biology.Front Biosci，2007，12：3117-3124.

[28]Kotton DN，Fine A.Lung stem cells.Cell Tissue Res，2008，331：145-156.

[29]Kim CF，Jackson EL，Woolfenden AE，et al.Identification of bronchioalveolar stem cells in normal lung and lung cancer.Cell，2005，121：823-835.

[30]Ivanova NB，Dimos JT，Schaniel C，et al.A stem cell molecular signature.Science，2002，298：601-604.

[31]Yoshida S，Shimmura S，Nagoshi N，et al.Isolation of multipotent neural crest-derived stem cells from the adultmouse cornea.Stem Cells，2006，24：2714-2722.

[32]Ling TY，Kuo MD，Li CL，et al.Identification of pulmonary Oct-4 stem/progenitor cells and demonstration of their susceptibility to SARScoronavirus（SARS-CoV）infection in vitro.Proc Natl Acad SciUSA，2006，103：9530-9535.

[33]Saito S，Liu B，Yokoyama K，et al.Animal embryonic stem（ES）cells：Self-renewal，pluripotency，transgenesis and nuclear transfer.Hum Cell，2004，17：107-115.

[34]Ventura JJ，Tenbaum S，Perdiguero E，etal.P38 alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation.NatGenet，2007，39：750-758.

[35]Pei XH，Bai F，Sm ith MD，et al.P18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers.Cancer Res，2007，67：3162-3170.

[36]Yanagi S，Kishimoto H，Kawahara K，et al.PTEN controls lung morphogenesis，bronchioalveolar stem cells，and onsetof lung adenocarcinomas inmice.JClin Invest，2007，117：2929-2940.

[37]Han J，Sun P.The pathways to tumor suppression via route p38.Trends BiochemSci，2007，32：364-371.

[38]Ca′nepa ET，Scassa ME，Ceruti JM，et al.INK4 proteins，a family of mammalian CDK inhibitors with novel biological functions.IUBMB Life，2007，59：419-426.

[39]Stiles B，Groszer M，Wang S，et al.PTEN lessmeansmore.DevBiol，2004，273：175-184.

[40]Lowry WE，Richter L.Signaling in adult stem cells.Front Biosci，2007，12：3911-3927.

[41]Besson A，Hwang HC，Cicero S，et al.Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and amultiple tumor phenotype.Genes Dev，2007，21：1731-1746.

[42]Ho MM，Ng AV，Lam S，et al.Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.Cancer Res，2007，67：4827-4833.

[43]Fukazawa T，Maeda Y，Durbin ML，et al.Pulmonary adenocarcinoma targeted gene therapy by a cancer and tissue specific promoter system.Mol Cancer Ther，2007，6（1）：244-252.

[44]Gutova M，Najbauer J，Gevorgyan A，et al.Identification of uPAR-positive chemoresistant cells in small cell lung cancer.PLoSONE，2007，2：e243.

[45]Collins AT，Berry PA，Hyde C，etal.Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res，2005，65：10946-10951.

[46]Konishi J，Kawaguchi KS，Vo H，etal.Gammasecretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.Cancer Res，2007，67：8051-8057.

[47]Zheng Q，Qin H，Zhang H，et al.Notch signaling inhibits growth of the human lung adenocarcinoma cell line A549.Oncol Rep，2007，17：847-852.

[48]Greenblatt DY，Vaccaro AM，Jaskula-SztulR，et al.Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.Oncologist，2007，12：942-951.

[49]Sims-Mouflada J，Izzo JG，Ajani J，etal.Sonic hedgehog promotesmultiple drug resistance by regulation of drug transport.Ocogene，2007，26（9）：5674-5679.

[50]Varjosalo M，Taipale J.Hedgehog signaling.JCell Sci，2007，120：3-6.

[51]Peacock CD，Wang Q，Gesell GS，et al.Hedgehog signalingmaintains a tumor stem cell compartment in multip lemyeloma.Proc Natl Acad Sci USA，2007，104：4048-4053.

[52]Bar EE，Chaudhry A，Lin A，et al.Cyclopaminemediated hedgehog pathway inhibition dep letes stem-like cancer cells in glioblastoma.Stem Cells，2007，25：2524-2533.

[53]Clement V，Sanchez P，de Tribolet N，et al.HEDGEHOG-GLI1 signaling regulates human glioma growth，cancer stem cell self-renewal，and tumorigenicity.CurrBiol，2007，17：165-172.

[54]Ehtesham M，SarangiA，Valadez JG，et al.Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells.Oncogene，2007，26：5752-5761.

[55]Ginestier C，Wicha MS.Mammary stem cell number as a determinate of breast cancer risk.Breast Cancer Res，2007，9：109.

[56]Patel M，Lu L，Zander DS，etal.ALDH1A1 and ALDH3A1 expression in lung cancers：Correlation with histologic type and potential precursors.Lung Cancer，2008，59：340-349.

[57]Gangemi R，Paleari L，Orengo AM，et al.Cancer stem cells：a new paradigm for understanding tumor growth and progression and drug resistance.Clin Lung Cancer，2009，10（3）：168-173.

[58]Hanahan D，Weinberg RA.The hallmarks of cancer.Cell，2000，100：57-70.

[59]Fong KM，Sekido Y，Gazdar AF，et al.Lung cancer：Molecular biology of lung cancer：clinical implications.Thorax，2003，58：892-900.

[60]WangWL，Healy ME，Sattler M，et al.Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.Oncogene，2000，19：3521-3528.